Lessons learned from a career in neuropathology by Weller, Roy O.
Free Neuropathology 2:27 (2021) Roy O. Weller 





Copyright: © 2021 The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited, a link to the Creative Commons license is provided, and any changes are 
indicated. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. 
 
Lessons learned from a career in neuropathology 
Roy O. Weller 
Faculty of Medicine, Southampton University, United Kingdom 
Address for correspondence: 
Roy O. Weller, BSc MD PhD FRCPath, Emeritus Professor of Neuropathology · Clinical Neurosciences · LD66, Mail point 806, South 
Academic Block, Level D · Southampton University Hospital Southampton SO16 6YD · United Kingdom 
rcn@soton.ac.uk 
Additional resources and electronic supplementary material: supplementary material 
Submitted: 09 October 2021 · Accepted: 12 October 2021 · Published: 25 October 2021 
Keywords: Clinical neuropathology, Research, Students, Lymphatic drainage of the brain, Alzheimer’s disease, Cerebral amyloid 
angiopathy, Personal reflections, Family 
Introduction 
Writing an Autobiography was probably the 
last thing on my mind when I was asked to add mine 
to a growing list of personal accounts published in 
Free Neuropathology. It was no easy task to summa-
rise my life in what I hope will be an interesting ac-
count for my readers. But, in the end, it has been re-
warding for me at least to state what I think have 
been the important events, ideas and attitudes that 
have shaped my life and career in Neuropathology 
and to recognise some of the many people who have 
taught, influenced, helped me and offered their 
friendship over many years. As for the lessons 
learned, I hope they will become apparent as the ac-
count proceeds. 
Early years  
I was born in a South-Eastern suburb of London 
a year before the outbreak of the Second World 
War. Our house was two miles from the River 
Thames and Woolwich Arsenal but, despite this vul-
nerable position, our home suffered no damage 
from bombing. It did mean, however, that there 
were many periods when we spent nights in an air-
raid shelter in the garden. I was too young to appre-
ciate the deprivations of wartime England and the 
terrible time that my parents endured. The first 
school that I attended was partially destroyed by a 
V2 rocket and my classmates and I transferred to an-
other school that had already been half destroyed 
by incendiary bombs. Despite this, all I can remem-
ber is a very happy childhood and education. At the 
age of 11 years, I transferred to a Grammar School 
in the centre of London, close to Tower Bridge. 
Founded in 1588, St Olave’s and St Saviour’s School 
that I attended had moved to a beautiful Early Vic-
torian building in 1840 to make room for the con-
struction of London Bridge station. The school is 
now in Kent and the original 1840 building is a 5-star 
hotel. I received a classical education with some 
concentration on languages; English, Latin, French, 
Greek and German have all been of great value to 
me, not only in medicine but also when I travelled 
widely in Europe as an undergraduate and during my 
postgraduate career. Science was also strong in my 
school and this enabled me to enter Guy’s Hospital 
Medical School in London as a medical student in 
1956. My motivation for studying medicine was 
mainly the attraction of the basic sciences, particu-
larly biochemistry, but I soon became enthralled 
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with patient contact and clinical medicine. During 
my undergraduate studies I spent a year, gaining a 
Bachelor of Science degree in Anatomy under excel-
lent tuition from Roger Warwick and Peter Williams 
who were both Editors of Gray’s Anatomy. I visited 
many of the Medical Schools in London for lectures 
and demonstrations during this year which gave me 
a clear insight into academic medicine and was prob-
ably a major factor in determining my postgraduate 
career in Neuropathology. 
Early postgraduate career 
Having completed my medical education, I took 
a teaching post in Anatomy at Guy’s and a research 
post with Professor John Cavanagh (Figure 1) to 
work on peripheral neuropathies, most especially 
experimental diphtheritic neuropathy in chickens 
(much to the amusement of my friends). My objec-
tive was to determine the ultrastructural sequences 
involved in the initial stages of segmental demye-
lination. John was an ideal supervisor at the begin-
ning of my research career as he would present me 
with a problem and leave me to solve it, only giving 
advice when asked; John also taught me the basis of 
the scientific method and how to view earlier find-
ings in my field with scepticism. I was introduced to
  
 
Figure 1. John B Cavanagh 1997. 
the technical aspects and analysis of transmission 
electron microscopy (TEM) that was still a relatively 
new technique. The skills I learnt at that time have 
served me throughout my career. In my first paper 
in 1965 1, I showed that, prior to breakdown of the 
myelin sheath in segmental demyelination, acid 
phosphatase-containing lysosomes gathered in cy-
toplasmic pockets on the inner aspect of the myelin 
sheath. This gave some indication of how the myelin 
was removed without damaging the axon that it en-
compassed.  
My second post at Guy’s was with Professor 
Colin Adams, who was a lipid histochemist of world 
renown. He had a gift for adapting techniques to 
identify individual lipids, particularly in atheroscle-
rosis and in multiple sclerosis. The major task for my 
PhD was to define the ultrastructure of intracellular 
lipid accumulations in atherosclerosis. This was no 
easy matter as the lipids are soluble in the organic 
solvents used in preparation for TEM. By a combina-
tion of polarised light microscopy, negative staining 
and routine TEM (Figure 2), I identified the multi-
lamellated structure of the liquid crystalline lipid 
droplets that appeared to be the template for ester-
ification of the cholesterol that they contain 2,3. 
It was during this period, that I started my edu-
cation in Clinical Neuropathology with Henry Urich 
at the London Hospital. Henry’s teaching was direct 
and very suitable for me in the early stages of my 
career. 
US-NIH-Fellowship at the Albert Ein-
stein College of Medicine in New York 
Having gained my Ph.D. in 1967, it was time for 
a change, so my wife, Francine, and our two chil-
dren, Adrienne, aged three and Timothy aged two 
years embarked on a boat for the USA. I had gained 
an US-National Institutes of Health (US-NIH) Post-
doctoral Fellowship in Neuropathology with Dr Rob-
ert Terry at the Albert Einstein College of Medicine 
in New York. It was a very different but highly stim-
ulating environment. Bob Terry was very generous 
with his time and ideas and this led to numerous in-
teresting discussions about pathology of the nerv-
ous system. I learned much about clinical neuropa-
thology from Bob and his colleagues, especially  
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Figure 2. Intracellular lipid droplets in atherosclerosis. Top left and then clockwise: TEM showing removal of lipid from cells during prep-
aration. Birefringent liquid crystalline droplets of cholesterol and phospholipids isolated from an atherosclerotic lesion. Similar droplets 
examined as negative stained TEM showing lamellated structure 2,3. 
 
 
Kinuko Suzuki. For my research, I investigated the ef-
fects of acute hydrocephalus upon the brains of 
adult rabbits, infant dogs and in biopsies from very 
young children. My main teacher and collaborator in 
this project was Henryk Wisniewski who was an ex-
cellent animal surgeon and experimenter. Henryk 
devised a technique for producing hydrocephalus by 
injecting highly viscous, but non-inflammatory, sili-
con oil through a lumbar intrathecal catheter into 
the posterior fossa of adult rabbits and young dogs 
to compress the fourth ventricle and impede the 
drainage of CSF. I examined the brains in large-area 
1 µm resin sections and by TEM. By sequential ex-
amination of the olfactory bulbs in adult rabbits and 
the walls of the lateral ventricles in infant dogs, we 
showed that as the ventricles dilate in the early 
stages of hydrocephalus, the ependyma ruptures 
and the flow of CSF into the periventricular white 
matter results in extensive CSF oedema with a mild 
degree of axonal degeneration. As hydrocephalus 
progresses, the CSF oedema subsides and the 
periventricular white matter displays extensive re-
active astrocytosis, and axonal degeneration 4,5. A 
similar sequence of changes was revealed in biop-
sies from very young children with acute hydroceph-
alus 6. These observations suggested that treating 
children with shunts in the early stages of hydro-
cephalus would preserve axons and improve prog-
noses. Our findings were confirmed several years 
later when CT scans clearly revealed the presence of 
periventricular oedema in the acute stages of hydro-
cephalus. The sequence of changes of ependymal 
rupture, increasing CSF oedema and destruction of 
periventricular white matter is well demonstrated in 
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Figure 3. Progressive Hydrocephalus in the mouse showing (a) Normal mouse brain. (b) Early stages of hydrocephalus with CSF oedema 
of the white matter. (c) Severe oedema with destruction of the white matter and preservation of grey matter. (d) SEM showing almost 
total destruction of the cerebral white matter and rupture of the ependyma 7. 
 
 
a congenital model of hydrocephalus in mice that I 
bred later when I returned to Guy’s (Figure 3). 
My family and I spent a most rewarding year in 
New York. We lived in an apartment block in the 
Bronx very near the Einstein. As the months pro-
gressed we adapted to the very low temperatures in 
the winter in New York and the high temperatures 
and humidity in the summer. Our children became 
bilingual through contact with their friends at 
nursery school; they would speak with a New York 
accent and vocabulary between themselves and 
their friends but spoke English when communicating 
with Francine and me. We explored Manhattan 
widely and travelled to a variety of cities in the US to 
appreciate the diversity of the country. As we finally 
left New York in September 1968, we travelled by 
Greyhound bus to a conference in New Orleans be-
fore flying home – quite an adventure!  
I have very pleasant memories of the team of 
people with whom I worked at the Einstein (Figure 
4). Through meetings of the American Association 
Neuropathologists (AANP), I remained in contact 
with Bob Terry for many years. Similarly, I retained 
contacts with Henryk Wisniewski, who had a very 
successful research career in demyelinating diseases 
and in Alzheimer’s disease. 
I have Kinuko-Suzuki to thank for my much of 
my training in diagnostic neuropathology and for her 
friendship that lasts to the present day. Of the 
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younger members of the team, Michael Shelanski 
became Professor of Pathology at Columbia Univer-
sity in New York, John Prineas returned to Australia 
as a Neurologist in Sydney to continue his research 
on multiple sclerosis. Jan Leestma developed a very 
successful career in Forensic Neuropathology in Chi-
cago; we are still in contact. 
After the photograph in Figure 4 was taken, 
Cedric Raine and Peter Spencer joined Bob Terry’s 
Department. Cedric developed a very successful ca-
reer in multiple sclerosis research. Peter Spencer 
moved into Toxicology and together with Herb 
Shaumburg published a large multi-author book on 
Clinical and Experimental Neurotoxicology to which 
my colleague in Southampton, John Mitchell, and I 
contributed a chapter on a fascinating Mexican seg-
mental demyelinating neuropathy due to ingestion 
of fruit and seeds of the Buckthorn plant (Karwinskia 
humboltiana) 8. It was rumoured that Mexican 
women would administer small amounts of the fruit 
or seeds to their husbands so that that they would 
feel weak and stay at home rather than spending the 
evenings drinking with their friends. 
Return to England 
In the fall of 1968, my family and I returned to 
England and I was appointed Lecturer in Pathology 
at Guy’s Hospital Medical School. I continued my 
close connections with Neuropathology by working 
in Peter Daniel’s Department at the Institute of Psy-
chiatry in London. My joint appointment allowed me 
to learn much from Peter and from his colleagues. I 
also broadened my knowledge of clinical diagnostic 
pathology in general by engaging in the analysis of 
renal biopsies in collaboration with David Turner, a 
fellow Pathologist, and Renal Physicians, Stewart 
Cameron and Chisholm Ogg. This was a very fruitful 
time as correlation of the ultrastructural changes in 
renal biopsies with clinical syndromes was still in its 
early stages. Together with Barry Nester, I published 
mid-20th-century diagnoses for three post-mortem 
kidneys that had been preserved by Richard Bright 
in the 1820-30s 9. For me, this was a valuable time 
for establishing contacts in London and elsewhere in 
the UK and for considering my ultimate career. Dur-
ing the 1970s I started to regularly attend 
Figure 4. Neuropathology 
group at the Albert Ein-
stein College of Medicine 
1968. First row, left to 
right: Drs Kinuko Suzuki, 
Mariene Lenger, Krystyna 
Wisniewska, Kytja Voeller 
and Anne Johnson. Second 
row, left to right: Drs Roy 
Weller, Henryk Wisniew-
ski, Robert D. Terry, John 
Andrews, Jan Leestma and 
Ivan Herzog. Third row, left 
to right: Drs Steven 
Shayvitz, Michael Shelan-
ski, Richard Snyder, John 
Prineas and Carlos Araoz. 
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Figure 5. Bad Dürkheim (Germany), 1971, Fotoschießen. As our colleague in the centre hit the target, the photo was taken with Jorge 
Cervós Navarro (left) and Roy Weller (right). The text book – “Pathology of Peripheral Nerves” (lower right) – was one product of my 
collaboration with Jorge. 
 
 
conferences abroad, mainly in Europe. This was es-
sential for my continuing education and for main-
taining contact with colleagues. 
I also benefitted by visiting many interesting 
countries and cities and meeting a great variety of 
different people. In 1971, I was fortunate to spend a 
short period in Berlin with Jorge Cervós Navarro that 
not only greatly increased my experience in neuro-
pathology, but also allowed me to appreciate life in 
East Berlin, then in the Soviet bloc, and to visit the 
famous Pergamon Museum and its marvellous ex-
hibits from Ancient Greece. It was through Jorge 
that I was introduced to the German Neuropathol-
ogy Society. At this time, trips to interesting nearby 
attractions were a feature of the German confer-
ences. Following a meeting in Heidelberg, for exam-
ple, we visited Bad Dürkheim and the Dürkheimer 
Wurstmarkt (sausage market but in reality the 
world’s largest wine festival) (Figure 5). I retained 
contact with Jorge for many years and together we 
wrote a book on the “Pathology of Peripheral 
Nerves” that was published in 1978. 
University of Southampton School of 
Medicine 
In early 1972, the opportunity arose to join the 
new Medical School that had been established in 
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1971 in the University of Southampton on the south-
ern coast of the UK. It was a combined National 
Health Service (NHS) and University post for which 
the job description was brief and to the point: “Pro-
vide a diagnostic service for Neuropathology for the 
Wessex Regional Neurological Centre, teach Neuro-
pathology and perform Research”. Following a thor-
ough assessment of the post and the environment 
in Southampton, I applied and was appointed to 
start in January 1973. I have never regretted the 
move to Southampton. My family and I moved to 
live in Winchester, just north of Southampton; an 
ancient Roman city and mediaeval capital of Eng-
land, one hour by train from London and 40 min by 
car from Heathrow.  
Clinical Neuropathology Service 
The 30 years that I worked in Southampton 
were delightful and I greatly appreciated the friend-
ship of my colleagues. My relationships with Clinical 
and University colleagues worked through collabo-
ration and mutual respect for each others’ areas of 
expertise. The two Neurosurgeons, Jason Brice and 
John Garfield, who were working in the Wessex Neu-
rological Centre (there are now 14 Neurosurgeons) 
when I arrived and the three Neurologists, Stanley 
Graveson, Peter Robinson and Lee Illis (now 21 Neu-
rologists) had very professional attitudes. Their aim 
was clearly to provide an excellent clinical service 
that required a high quality and rapid diagnostic 
Neuropathology service from me, together with 
weekly Multidisciplinary Team Meetings to discuss 
individual patients. I had soon realised that my clin-
ical colleagues had many challenges and that my 
role was to provide them with all the assistance that 
I could. As we built up an atmosphere of mutual col-
laboration my life in Southampton remained stable 
and pleasurable. 
Neuropathology in Southampton had a defined 
laboratory with its own staff but it was part of a 
larger Department of Histopathology/Cell Pathology 
with Prof Dennis Wright at its head. This arrange-
ment had many advantages, not least the wide 
range of expertise and facilities. Regular clinical pa-
thology and research meetings allowed the sharing 
of ideas and information about new developments. 
Social activities were enthusiastically pursued which 
helped with cohesion of the Department; there was 
also a constant circulation of Pathology trainees 
from the UK and other countries through Neuropa-
thology providing a very interesting international 
environment. There were some disadvantages, such 
as competition for space and staff but the ad-
vantages heavily outweighed the disadvantages. 
From the time that I arrived in Southampton, I 
was responsible for Neuropathological Services for 
the Wessex Region of some 3 million people. Richard 
Goodbody, who had long been involved in brain tu-
mour diagnoses and in analysing post-mortem 
brains, very helpfully continued as part-time in this 
field. I covered brain, nerve and muscle biopsies, 
ophthalmic biopsies together with post-mortem 
brains and teaching sessions for trainee pathology 
staff, clinicians, medical students and nurses. My 
workload was very high and I was careful to priori-
tise so that I could cover all fields for which I was 
employed. I soon acquired a very extensive experi-
ence of diagnostic neuropathology and felt able to 
compile textbooks on Neuropathological subjects 
(see later section).  
During the 1970s, there were rapid advances in 
clinical neurology, neurosurgery and neuroradiology 
with the introduction of CT scanning and MRI that 
had a huge influence on diagnostic neuropathology. 
Tumours and other lesions in the brain and spinal 
cord were well visualised, but instead of reducing 
the workload in Neuropathology, the number of bi-
opsies steadily increased. There were significant ad-
vances in the technical aspects of Neuropathology. 
Immunocytochemistry, for both frozen and paraffin 
sections, and later genetic techniques were incorpo-
rated into the diagnostic Pathology and Neuropa-
thology services. Ray Hunt and Barbara Davis led the 
technical team for Neuropathology and together 
with Phillip Steart, Jean Buontempo and Judy 
Mepham were always very anxious and able to ad-
vance the scope and quality of the service.  
Trainees, fellows and staffing in 
clinical neuropathology 
In addition to trainee Pathologists and Neuro-
surgeons from Southampton rotating through Neu-
ropathology, a number of Fellows from other Insti-
tutions joined me over the years. Ricardo Campora 
came in the 1970s from Seville and worked with me 
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for a year before returning to Spain to practice Neu-
ropathology. Ricardo is extremely able and became 
Professor of Pathology and head of Department in 
Seville. I am still frequently in touch with Ricardo and 
his wife Conchita. For a few years I taught a Neuro-
pathology course in Seville and received tremen-
dous hospitality there; we also meet on occasion in 
London. Laura Chavez from Mexico City worked with 
me as did Markus Tolnay from Basel and Jim Lowe 
from Nottingham; all have had successful careers in 
Neuropathology and we remain in contact. 
In the 1980s John Grant came to work with me 
as a trainee in Neuropathology. This changed my life 
as it gave me much more flexibility in how I spent my 
time. John was always very reliable and a great in-
spiration; when he left Southampton John gained 
experience in Zürich before embarking on a very suc-
cessful career as a Consultant Pathologist in Cam-
bridge, where he has been Head of Department for 
a number of years. Patrick Gallagher was a Consult-
ant Cardiac Pathologist who also joined the Neuro-
pathology diagnostic team which again was of great 
benefit to the Service. David Ellison arrived as a 
trainee in Neuropathology in the early 1990s and 
soon made significant progress in research into the 
genetics of brain tumours. David became a Consult-
ant Neuropathologist in Southampton before gain-
ing a Professorship in Newcastle and then moving to 
Memphis, Tennessee, to pursue his world-re-
nowned career in the pathology and genetics of 
childhood brain tumours. 
Soon after David Ellison left Southampton, 
James Nicoll came from Glasgow; he brought tre-
mendous expertise in dementia research, particu-
larly in the roles of microglia. James has made a con-
siderable contribution to the study of post-mortem 
brains in patients following immunotherapy for Alz-
heimer’s disease. I retired in 2003 and left Clinical 
Neuropathology in Southampton in the extremely 
capable hands of James Nicoll. After my retirement 
the Clinical Neuropathology Service was augmented 
by two very competent Consultants, Mark Walker 
and Mark Fabian.  
Research 
In this account, I take a personal view of how 
my research progressed in Southampton and I in-
clude the names of some, but by no means all, of the 
many people involved. Serendipity and the views of 
my colleagues worldwide played a major role in how 
my research progressed. I am indebted to the 
 
Figure 6. Roxana Carare 
and her group. Students 
and technical staff with 
Cheryl Hawkes (right 
front) next to Roy Weller 
and Roxana Carare. 
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students and postdocs who contributed so much to 
our research programme and stimulated its pro-
gress.  
A number of themes initially emerged from my 
research including structural changes in Peripheral 
Neuropathies and Myopathies, regeneration in 
nerves and muscle and detailed analyses of brains 
with Growth Hormone-related Creutzfeldt-Jakob 
disease. Postdoctoral fellows, Lawrie Haynes and 
Gary Caine used tumour biopsy material to investi-
gate the effects of pharmacological agents on tissue 
culture preparations of gliomas. With the introduc-
tion of immunocytochemistry for paraffin sections 
developed by Dennis Wright and his colleagues in 
our department, we were able to investigate the up-
take of proteins by normal and neoplastic astro-
cytes.  
Major research themes 
Four Major Interconnected Themes dominated 
most of my research in Southampton and led to ad-
vances and revision of Scientific Concepts. (i) The 
structure of the leptomeninges and their relation-
ships to the brain. (ii) The detailed pathways for lym-
phatic drainage of the brain. (iii) The relationship be-
tween age-related failure of lymphatic drainage and 
the accumulation of amyloid-β (Aβ) in artery walls in 
Cerebral Amyloid Angiopathy (CAA) and in the brain 
in Alzheimer’s disease. The latter advances were 
mainly through the work of Roxana Carare, who fol-
lowing completion of her PhD formed her own re-
search group that included Cheryl Hawkes and many 
others (Figure 6). Roxana’s work progressed to iden-
tify potential therapies for Alzheimer’s disease and 
CAA and to early Clinical Trials. Roxana is now Pro-
fessor of Clinical Anatomy in Southampton. (iv) 
Through a very fruitful and lasting collaboration with 
Britta Engelhardt in Bern, Switzerland, we also inves-
tigated the relationship between lymphatic drainage 
of the brain and neuroimmunological diseases with 
relevance to disorders such as Multiple Sclerosis. 
A list of over 200 peer-reviewed papers that my 
colleagues and I published can be obtained from 
PubMed. I will only cite a few of those papers in the 
following text. 
 
Why do research? 
For me, the main reasons for engaging in re-
search are to satisfy my curiosity and to take the op-
portunity to present unique data to colleagues at 
Scientific Conferences and in Scientific Journals. I 
had been exposed to research during my BSc course 
at Medical School and in my early postgraduate 
years working with John Cavanagh and Colin Adams. 
Bob Terry encouraged research in all his fellows and 
led by example. By the time I arrived in Southamp-
ton, research was well ingrained within me. South-
ampton has been, for me, an ideal environment for 
research through excellent facilities and multiple 
disciplines within the University available for consul-
tation and collaboration. With a heavy diagnostic 
workload in biopsies and post-mortem brains, I was 
exposed to many unsolved problems in Human Neu-
robiology and Neuropathology that provided a stim-
ulus for hypothesis-driven experimental research. 
Another important stimulus for research was the re-
quirement that each Medical Student in Southamp-
ton perform a research project from October to May 
in the fourth year of the course. This meant that a 
constant stream of two or three highly intelligent, 
hard-working enthusiastic 22 year old students 
worked in Neuropathology each year with their indi-
vidual projects but collaborating closely with BSc 
and PhD students, Post-Docs and Research Fellows. 
My strategy was to begin a research theme with 
straight-forward observational projects for the 
Medical Students that generated hypotheses to 
drive experimental research for the PhD students 
and Postdoctoral Fellows. Many students presented 
papers at British Neuropathological Society (BNS) 
Meetings and published papers in peer-reviewed 
scientific journals. All groups benefitted their future 
careers by acquiring skills in spoken and written 
communication. 
How did I benefit from students and others in-
volved in research projects? 
The students educated me by their observa-
tions, the papers that they read and from the 
knowledge that they had gained in their recent med-
ical education. Retaining an open mind was very im-
portant: each student was given a problem to solve 
but advised not to read the previous literature until
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Figure 7. SEM of the meningeal surface of the human cerebral cortex showing the arachnoid mater (Ar) and branches of an artery (A) 
spreading over the surface of the pia mater (P). The circle depicts the point at which a branch of the artery enters the cortex and how the 
pia mater is reflected on to the artery thus separating the subarachnoid space from the brain. (b) is an enlarged view of the reflected pia 
mater (P). Artefactual holes are seen in the pia in this post-mortem specimen. Arrow (lower left) identifies a filiform trabecula crossing 
the subarachnoid space 10. 
 
 
they had results and could form their own opinions. 
There were numerous occasions upon which stu-
dents burst into my office crying “The literature is 
wrong!” In this way they built up a healthy scepti-
cism for previous findings. I advised students not to 
believe anything they read and not to believe any-
thing that I told them until they had verified it for 
themselves.  
Structure of the human leptomeninges and their 
relationship to the brain and blood vessels 
Although my interest in fluid balance in the 
brain started with my work on Hydrocephalus in 
New York, it was reawakened in Southampton by 
student projects using Scanning Electron Micros-
copy (SEM) to examine human leptomeninges. Mar-
garet Upton 11 identified the intricate pattern of 
channels by which CSF passes through arachnoid 
granulations to the blood in venous sinuses. Marga-
ret Hutchings made a startling discovery in 1986 us-
ing SEM on the surface of human brain by showing 
that the pia mater is reflected from the surface of 
the brain on to arteries and veins in the subarach-
noid space thus separating CSF in the subarachnoid 
space from the brain 10 (Figure 7). This exploded the 
longstanding concept that there was a direct com-
munication between CSF and brain. Margaret also 
showed that erythrocytes in Subarachnoid Haemor-
rhage do not penetrate the pia mater to enter the 
brain. We later confirmed that solutes and macro-
phages do pass through the pia mater that forms a 
continuous sheet on the surface of well-fixed normal 
brain as shown by Ruth Alcalado 12. No pores in the 
pia have been identified by TEM and the holes seen 
in SEM images are probably post mortem or fixation 
artefact. 
In the 1980s, En-Tan Zhang came from Beijing 
to work with me in Southampton. En-Tan is a medi-
cally qualified Anatomist and he made a major con-
tribution to establishing the relationships between 
the leptomeninges and arteries as they enter the 
brain. Using well fixed human biopsy brain material, 
En-Tan showed that a single layer of pia mater coats 
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arteries as they enter the surface of the cerebral cor-
tex and that there is no “periarterial space” between 
the glia limitans and the artery wall 13. Astrocytes in 
the glia limitans, pia mater, smooth muscle cells and 
endothelium together with the intervening layers of 
basement membrane form a compact structure, 
with no perivascular space (Figure 8). The long-de-
scribed Virchow-Robin spaces do not exist in the cor-
tex and if present they are mainly due to swelling of 
astrocyte processes from poor fixation as empha-
sised by Milton Brightman in the 1960s. En-Tan’s ob-
servations completely changed our perception of 
the relationship between CSF and the brain. Subse-
quently, Roxana Carare’s group showed that tracers 
from the CSF enter the brain, not along perivascular 
spaces (as there are none) but along basement 
membranes between the glia limitans and the single 
layer of pia mater that surrounds each artery as it 
enters the brain 14. Basement membranes between 
smooth muscle cells in the tunica media were later 
shown by Roxana Carare to be the pathways for flow 
of fluid and solutes out of the brain. Due to the ab-
sence of periarterial spaces, there are no periarterial 
pathways for the entry of inflammatory cells from 
the CSF into the brain.  
Periarterial spaces do form in other the parts of 
the brain, especially in the basal ganglia and around 
arteries in the white matter. At both of these sites, 
arteries are surrounded by two layers of pia mater 
and the periarterial space develops between 
them 15,16. 
Lymphatic drainage of the brain 
There are two extracellular fluids associated 
with the brain and spinal cord: (i) CSF in the ventri-
cles and subarachnoid spaces and (ii) Interstitial 
Fluid (ISF) in the extracellular spaces of the brain and 
spinal cord. Pathways for lymphatic drainage of CSF 
are almost completely separate from lymphatic 




Figure 8. TEM of a well-fixed human cortical artery showing part of the wall and surrounding brain. The layers of glia limitans, pia mater, 
smooth muscle cells and endothelium adjacent to the lumen are all compacted with no preriaterial space (see also 13).
Free Neuropathology 2:27 (2021) Roy O. Weller 




Lymphatic drainage of CSF 
Shinya Kida, a Neurosurgeon from Japan, 
joined us in Southampton in the early 1990s and em-
barked upon a search for the drainage pathways for 
CSF in the rat with a medical student Andreas Pan-
tasis. Lymphatic drainage of CSF to cervical lymph 
nodes had been demonstrated by Schwalbe in 1869, 
and Bradbury and Cserr showed in the 1980s that 
lymphatic drainage of CSF occurred through the 
cribriform plate of the ethmoid bone but the details 
were unclear. Shinya and Andreas 17 demonstrated 
direct drainage of Indian ink tracer from the sub-
arachnoid space along distinct vessels that pass 
through the cribriform plate alongside olfactory 
nerves into the nasal submucosa en route to cervical 
lymph nodes. Such channels were also shown to ex-
ist in post mortem humans brains by the injection of 
Myodil tracer into the CSF 18 and by reconstruction 
from serial sections of the human cribriform plate 
and nasal mucosa by Effie Djuanda in her fourth year 
medical student project 19. Other channels for drain-
age of CSF identified in these studies included dural 
lymphatics and the sheaths of cranial nerves 17,20. 
Drainage of CSF by the nasal route has been demon-
strated in humans using PET scanning 20. 
The balance between lymphatic drainage of 
CSF to cervical or lumbar lymph nodes and drainage 
through arachnoid granulations has yet to be deter-
mined. The small size and paucity of arachnoid villi 
in the rat suggests that they are quantitatively less 
important for the drainage of CSF in rodents than 
lymphatic drainage. In humans, arachnoid granula-
tions do not develop until the age of two years which 
suggests that lymphatic drainage may also be an im-
portant route for the drainage of CSF in Humans. 
Arachnoid granulations may compensate for varia-
tions in CSF pressure that occur with change of body 
position; this speculation still requires direct verifi-
cation.  
Lymphatic drainage of Interstitial Fluid (ISF) and 
solutes from the brain 
There are no conventional lymphatic vessels in 
the brain or spinal cord. In the 1980s Helen Cserr 
and her colleagues 21 injected minute amounts of ra-
dioactive human serum albumin as a tracer into the 
basal ganglia of the rat brain, and showed that the 
tracer drained to cervical lymph nodes along the 
walls of cerebral arteries. Only 10-15% of tracer 
leaked into the CSF emphasising that the pathways 
for lymphatic drainage for CSF from the subarach-
noid spaces are separate from drainage of ISF from 
the brain itself. 
En-Tan Zhang attempted to define the drainage 
pathways for ISF in more detail in the late 1980s by 
injecting Indian ink particles directly into the basal 
ganglia of the rat brain. The ink particles tracked 
along the outside of arteries, were taken up by peri-
vascular macrophages and remained in situ 22. This 
technique did not identify the drainage pathways for 
ISF but did identify a pathway that was later used for 
Convection-Enhanced Delivery (CED) of drugs di-
rectly into the brain 23. 
The results from En-Tan’s work led to discus-
sions with Alex Roher from Phoenix, Arizona, who 
suggested that cerebral amyloid angiopathy (CAA) 
may be related to periarterial lymphatic drainage of 
the brain. We subsequently published a joint paper 
in American Journal of Pathology in 1998 with the 
title “Cerebral Amyloid Angiopathy: Amyloid β Accu-
mulates in Putative Interstitial Fluid Drainage Path-
ways in Alzheimer’s Disease“ 24. 
Breakthrough 
A major breakthrough in our research on lym-
phatic drainage of the brain came from the work of 
Roxana Carare in her PhD project that I supervised 
jointly with Hugh Perry. Roxana injected formalin-
fixable fluorescent dextrans or soluble Amyloid-β 
(Aβ) into mouse brains and examined the drainage 
pathways by confocal microscopy. In her paper, “So-
lutes, but not cells, drain from the brain parenchyma 
along basement membranes of capillaries and arter-
ies: significance for cerebral amyloid angiopathy and 
neuroimmunology” 25, Roxana defined the pathways 
for the lymphatic drainage of fluid and solutes from 
brain tissue that we later termed the “Intramural 
Peri-Arterial Drainage (IPAD) Pathways” 14. Follow-
ing the injection of minute volumes (0.5 µL) of tracer 
into the caudate nucleus of the mouse brain, tracer 
spread through the extracellular spaces of the brain 
and within 5 mins had entered the lymphatic drain-
age pathway (IPAD) in the basement membranes of 
capillaries and basement membranes between 
smooth muscle cells in the tunica media of cerebral 
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arteries. The drainage pathway (IPAD) extended into 
leptomeningeal arteries. No tracer was seen around 
veins in normal animals following intracerebral in-
jections although animals with age-related impair-
ment of IPAD did show some tracer around veins 26. 
Confusion 
Considerable confusion in the scientific litera-
ture has resulted from the injection of excessive vol-
umes of tracer into the mouse brain that results in 
leakage of tracer into the CSF giving the false impres-
sion that lymphatic drainage of the brain occurs via 
the CSF. Furthermore, injecting excessive amounts 
of tracer into the brains of mice and not examining 
the animals until 1 hour later, after IPAD is complete, 
result in pooling of tracer around veins and has given 
the erroneous impression that lymphatic drainage 
of the brain is along the walls of veins.  
Supporting evidence for IPAD in the human brain 
CAA in mice and humans provides convincing 
supporting evidence that IPAD is the route for lym-
phatic drainage of fluid and solutes from the brain 
parenchyma. (i) The pattern of distribution of Aβ in 
capillary and artery basement membranes in CAA 
exactly mirrors the distribution of Aβ and other trac-
ers in IPAD pathways in the animal experiments 27. 
(ii) CAA occurs in transgenic mice in which there is 
excessive production of Aβ in neurons; in these mice 
the origin of the Aβ is definitely from cells in the 
brain 28. 
Age-related failure of elimination of Aβ by IPAD 
is associated with CAA and Alzheimer’s disease 
By combining experimental studies in the 
mouse with observations of human CAA and Alz-
heimer’s disease, the following main conclusions 
have been reached as summarised in 29. IPAD is im-
paired by age-related changes in the walls of arteries 
and by CAA 26. Both theoretical models and experi-
mental studies suggest that the motive force for 
IPAD is derived from waves of smooth muscle cell 
contraction (Vasomotion) that pass along the walls 
of cerebral arteries in the opposite direction to 
blood flow, but in the same direction as IPAD 29,30. 
Age and the presence of apolipoprotein E ε4 
(APOE4) is associated with the impaired IPAD 31 and 
this correlates with age and APOE4 as major risk fac-
tors for Alzheimer’s disease and CAA in humans. CAA 
also affects capillaries; painstaking cutting of hun-
dreds of serial transverse sections of arteries in re-
gions of capillary CAA by Hong Yeen Yow (BSc stu-
dent) suggest that capillary CAA is associated with 
thrombotic occlusion of penetrating cortical  
arteries 19. 
Age-related impairment of IPAD appears to be 
associated with loss of Homeostasis in the brain as 
reflected by accumulation of fluid in White Matter 
Hyperintensities on MRI and the failure of elimina-
tion of Aβ with age and in Alzheimer’s disease. Dila-
tation of periarterial spaces in the white matter is 
associated with CAA and probably reflects failure of 
IPAD.  
Translational neuroscience: Therapeutic strate-
gies for CAA and Alzheimer’s disease: Facilitating 
IPAD 
For the past 20 years there have been many tri-
als of Immunotherapy for Alzheimer’s disease but 
with little success in reducing cognitive decline in 
the treated patients. Studies of post mortem brains 
following Aβ immunotherapy have shown that alt-
hough Aβ plaques are removed from the cerebral 
cortex both arterial and capillary CAA are increased 
in severity 32,33. It does appear that age-related fail-
ure of IPAD is a rate-limiting step in Aβ immunother-
apy and this emphasises the importance of facilitat-
ing IPAD in the treatment of CAA and Alzheimer’s 
disease. 
Potential new therapeutic strategies could act 
via IPAD by modulating vasomotion as the postu-
lated motive force for IPAD. This may be accom-
plished by stimulating contraction of vascular 
smooth muscle cells directly or through their nerve 
supplies. Another therapeutic possibility is the use 
of chaperone molecules to enhance the clearance of 
Aβ along the basement membranes that form the 
IPAD pathways 29.  
Lymphatic drainage of the brain and neuroim-
munology 
The brain is an immunologically privileged  
site 34 as shown by experiments in which skin allo-
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grafts implanted in the brain survive for longer peri-
ods than allografts in other organs. Rapid rejection 
of brain allographs does occur, however, when sim-
ilar allografts are implanted into the animal’s skin. 
The leptomeninges and CSF spaces do not show the 
same immunological privilege as brain tissue 34. One 
of the major differences is that CSF drains directly 
into lymphatic vessels that allow fluid, antigens and 
antigen presenting cells to drain directly from the 
CSF to lymph nodes. IPAD pathways are too narrow 
to allow the traffic of APCs from the brain to lymph 
nodes 25. This may be a major factor in immunologi-
cal privilege of the brain. 
Cervical lymph nodes have a major role in im-
munological reactions in the brain as shown by Mar-
ian Phillips, Dong Sun (Ph.D. students), Jonathan





Lake and Michelle Needham (BSc medical students) 
and by Jon Laman and his group 35-37. Our first task 
was to enhance experimental autoimmune enceph-
alomyelitis (EAE), in the cerebral hemispheres of 
rats so that accurate measurements of inflammation 
could be made. In most models of EAE following in-
jection of antigen into the footpads, inflammation is 
concentrated in the spinal cord. However, Shinya 
Kida had previously shown that a wound to the sur-
face of the rat cerebral cortex in the form of a cry-
olesion resulted in activation of perivascular macro-
phages throughout the cerebral hemispheres. Thus 
we showed that a cryolesion on the surface of the 
cortex in rats, 7 days post injection (dpi) of EAE anti-
gens into the foot pad of the rat resulted in en-
hanced inflammation in the cerebral hemispheres at 
day 15 dpi. Removal of cervical lymph nodes on day 
7 dpi resulted in a 50% reduction in EAE-related in-
flammation at day 15 dpi. These results suggest that 
cervical lymph nodes play a key role in cerebral  
EAE 35. Furthermore, adoptive transfer of lympho-
cytes from animals with cryolesion EAE resulted in a 
predominance of EAE lesions in the cerebral hemi-
spheres in naive recipients rather than spinal cord 
EAE 36. Our involvement in neuroimmunology 
brought us into contact with Britta Engelhardt in 
Bern and her excellent studies on the receptor-me-
diated entry of lymphocytes into the brain  








Figure 9. Summary of pathways for the flow of fluid and solutes 
into and out of the brain. (a) CSF flows into the brain along base-
ment membranes shared by pia mater and glia limitans on outer 
surfaces of cortical arteries as they penetrate the brain. (b) In-
terstitial fluid (ISF) and solutes such as Aβ flow out of the brain 
to lymph nodes along IPAD pathways. (c) Details of the pathway 
by which CSF flows into the cerebral cortex along pial-glial base-
ment membranes and then enters the brain to flow out along 
IPAD. Reproduced from 29. Original Design by Roy Weller and 
graphic by ArtFact Graphics. 
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Award of the Gertrud-Reemtsma prize 
for International Translational Neuro-
science 2020 
 
Figure 10. The prize winners of the International Prize for Trans-
lational Neuroscience 2020: Left to right: Roy Weller, Maiken 
Nedergaard, and Mathias Jucker. 
 
 
I was greatly honoured by the award of the In-
ternational Prize for Translational Neuroscience by 
the Council of the Gertrud Reemstma Foundation, 
administered by the Max Planck Society. The prize 
had been the K. J. Zülch-Prize until 2019 with many 
famous and worthy winners from 1990. I was 
awarded the prize together with Maiken 
Nedergaard and Mathias Jucker (Figure 10). My 
award was for the Southampton group’s “Ground-
breaking scientific discoveries in the field of Lym-
phatic Drainage of the brain and its relationship to 
the aetiology of Alzheimer’s disease”. Of course the 
prize was awarded as much of the work performed 
by the many medical students, Ph.D. students and 
postdocs who worked with me in Southampton. 
Roxana Carare, Cheryl Hawkes, En-Tan Zhang, 
Shinya Kida and Dong Sun deserve special mention. 
Nevertheless, I felt it was a great honour for our 
group. Due to COVID-19 I could not attend the 
award ceremony on September 10th 2020 in Co-
logne, Germany, in person so I presented my lecture 
on Zoom.  
Management roles 
Throughout most of my career in Southampton 
I was involved in management in the NHS, South-
ampton University, and in Regional, National and In-
ternational Organisations. It was part of my role to 
assist with the organisation of the Institutions to 
which I belonged. Furthermore I was rewarded by 
meeting many interesting people while performing 
management tasks. 
Within two years of my arrival in Southampton, 
I became Chairman of the whole of Pathology; this 
was in a very active period when all Pathology de-
partments were moving into a newly-built Pathology 
block. At that time, in the mid-1970s, there were vir-
tually no management courses and I learnt the nec-
essary skills by observing others, how they chaired 
meetings, coordinated events and managed people 
so that the whole system ran smoothly and within 
budget.  
Soon after my promotion to Professor of Neu-
ropathology in 1978, I became Deputy Dean of Med-
icine, which included, among other very interesting 
tasks, chairing the Committee for Selection of Med-
ical Students; this gave me insight into the great va-
riety of skills exhibited by the applicants to Medical 
School. Following my four-year term as Deputy 
Dean, I was appointed Chairman of the University Li-
brary Committee. Not only did this coincide with the 
delivery to the Library of the papers of the Duke of 
Wellington, but it was also the time that the Library 
acquired the papers of Lord Louis Mountbatten. The 
papers were markedly different in their condition. 
The Wellington papers were written with Indian ink 
on parchment such that they could be cleaned with 
large India rubber balls in sinks of cold water. The 
Mountbatten papers, on the other hand, were the 
fourth or fifth typed copy and required urgent tran-
scription. 
For some 20 years I chaired various Regional 
and National Committees that ensured high quality 
training of Pathologists locally in Wessex and nation-
ally through the Royal College of Pathologists. This 
was the time during which Neuropathology became 
an independent discipline within the Royal College 
of Pathologists and training and examinations were 
formalised. The establishment of the European Con-
federation of Neuropathological Society (EuroCNS) 
also allowed a European program of education and 
qualifications in neuropathology to be established.  
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British Neuropathological Society 
The British Neuropathological Society (BNS) 
plays valuable roles in Neuropathology in the UK, 
both in monitoring the quality of clinical neuropa-
thology and in encouraging research. The annual 
BNS scientific meeting is always very interesting and 
informative. In 2000, the BNS organised an Interna-
tional Neuropathology Society Congress in Birming-
ham, UK, with some 700 delegates. I chaired the 
committee that organised the scientific programme 
and David Graham was President. Due to the hard 
work and diligence of my many colleagues, the Con-
gress was a great success. I was elected President of 
the BNS for 2001-2002. 
Major figures such as Hume Adams and David 
Graham in Glasgow, James Ironside and Jeanne Bell 
in Edinburg, Raj Kalaria in Newcastle, James Lowe in 
Nottingham, Seth Love in Bristol, Peter Lantos in 
London and many others played very significant 
roles in organising the BNS such that the BNS Con-
ferences attracted significant numbers of Neuropa-
thologist from Europe, USA and other countries.   
Editor of Neuropathology and Applied 
Neurobiology 
In 1975, John Cavanagh founded the Journal 
Neuropathology and Applied Neurobiology (NAN), 
that was adopted by the BNS as the Society Journal. 
I followed John as Editor in Chief of NAN between 
1988 and 1998. This was a most rewarding time for 
me, organising the publication of research articles 
and review articles from an international body of au-
thors. I learned much about the organisation of sci-
entific journals and gradually NAN started to make a 
profit that has benefited the BNS financially. John 
had organised NAN with the original publishers, 
Blackwell, so that the profits were shared between 
the publisher and the BNS. Elizabeth Whelan was my 
main contact with the publisher and our relationship 
was excellent throughout my time as editor, largely 
due to Elizabeth’s skill and dedication. James Lowe 
followed me as editor in 1999 and there has been a 
succession of very successful Editors since. The Im-
pact Factor of NAN has increased steadily from 3.9 
in 2014 to 7.09 in 2019. Tom Jacques is the present 
Editor in Chief and NAN continues to play a signifi-
cant role in international neuropathology. 
Editorial boards 
I have been a member of Editorial Boards of a 
number of Journals but the ones I remember in par-
ticular are the Boards of Brain Pathology, Acta Neu-
ropatholgica and more recently, Free Neuropathol-
ogy. Werner Paulus made a particular impression on 
me as editor of Acta Neuropatholgica; his very in-
spired decisions on which papers to accept for the 
Journal ensured that the Impact Factor for Acta Neu-
ropatholgica rose to 18. Werner is the founding Edi-
tor in Chief of Free Neuropathology. 
Books published 1978-2013 
I decided to harness the clinical material asso-
ciated with the diagnostic service to publish a num-
ber of Text Books; this was partly as a self-education 
exercise. Some books I wrote alone or with another 
single author or I acted as Editor as well as a contrib-
utor. The rewards for my efforts were that writing 
and editing consolidated my knowledge of Neuropa-
thology and built lasting friendships with multiple 
authors who showed great tolerance for my edito-
rial changes. 
My first was “Pathology of Peripheral Nerves” 
by R O Weller and J Cervós-Navarro, published by 
Butterworths, London in 1978 and my second re-
sulted from a course that we ran in Southampton: 
“Clinical Neuropathology.” A multi-author book ed-
ited by R O Weller, M Swash, DL McLellan and C L 
Scholtz, published by Springer Verlag, Berlin in 1983. 
The Japanese edition of “Clinical Neuropathol-
ogy”was translated by T Mientani and published by 
Nishimura Co Ltd in 1983. 
“A Colour Atlas of Neuropathology” by R O 
Weller, published by Harvey Miller and Oxford Uni-
versity Press in 1984 and I contributed to “McAl-
pine’s Multiple Sclerosis”, by W B Matthews, E D 
Acheson, J R Bachelor and R O Weller. Edited by W. 
B. Matthews, published by Churchill Livingstone, Ed-
inburgh in 1985. 
As part of “Systemic Pathology”, third edition: 
General Editor, W St C Symmers. I edited a multi-au-
thor “Volume 4: Nervous System, Muscle and Eyes”, 
published by Churchill Livingstone, Edinburgh in 
1990. In 2002 I contributed to “Diagnostic Pathology 
of Nervous System Tumours”, by J W Ironside, T H 
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Moss, D N Louis, J S Lowe and R O Weller, published 
by Churchill Livingstone, Edinburgh. 
I was appointed Director of the Book Series 
sponsored by the International Society of Neuropa-
thology (ISN), publishing “Neurodegeneration. The 
molecular pathology of dementia and movement 
disorders”, second Edition. Edited by D W Dickson 
and R O Weller. Series director, R. O. Weller. Pub-
lished by Wiley-Blackwell, Chichester, UK in 2011. As 
“Neurodegeneración”, the book was published in 
Spanish by Editorial Medica Panamericana, Madrid 
and Buenos Aires. The second book in the ISN series 
was “Muscle Disease: Pathology and Genetics”, sec-
ond edition. Edited by H H Goebel, C A Sewry and R 
O Weller, Series director, R. O. Weller Published by 
Wiley-Blackwell, Chichester, in 2013. 
I also contributed Chapters to a number of 
books including: Gray’s Anatomy, Greenfield’s Neu-
ropathology, Clinical and Experimental Neurotoxi-
cology and Histology for Pathologists.  
International Conferences and visits to 
other Neuropathology units 
Attending conferences was essential for my 
continuing education and for maintaining contact 
with colleagues. I also benefitted from visiting many 
interesting countries and cities throughout the 
world and meeting a great variety of different peo-
ple. I regularly participated in the annual meetings 
of the British, French and German Neuropathology 
Societies and occasionally, the Scandinavian and 
Italian Neuropathology Society Meetings. I devel-
oped strong friendships with many members of 
those societies; Francoise Gray, Jacqeline Mikol and 
Homa Adle-Biassette to name but a few. 
A particular favourite conference of mine was 
the meeting of the Swiss Society of Neuropathology 
in St. Moritz every two years. Not only was the meet-
ing held amidst beautiful scenery, the train journey 
was spectacular and there was ample opportunity 
for skiing and social interaction for discussing scien-
tific data. I made many friends at these meetings. In 
addition to European meetings, I attended many 
conferences in the USA, including annual meetings 
of the American Association of Neuropathology. 
Other Conferences to which I contributed include 
those in India, Australia and Brazil. Photographs of 
many of the friends that I made at these interna-
tional meetings appear in an excellent autobiog-
raphy by Sam Ludwin 38.  
In 1988 Paul Kleihues kindly invited me to work 
for four months in Zürich. There was a most inter-
esting group of young Neuropathologists working 
with Paul at the time, Otmar Wiestler, Andreas von 
Deimling and Adriano Aguzzi all of whom subse-
quently developed very successful careers and with 
whom I developed lasting friendships. While work-
ing for six weeks in Harare in Zimbabwe in 1991, I 
was involved mainly in teaching with occasional and 
most stimulating visits by car to other parts of the 
country. Martin Lewis was there at the time; he was 
an English pathologist working in Florida and we 
made a long tour around Zimbabwe in a 1968 Mer-
cedes car that he had borrowed. Martin had exten-
sive experience of Africa that is outlined in his book 
“The call of Africa”. 
Particularly rewarding were my visits to Beijing 
after my retirement at the invitation of Wei Wei 
Zhang. Quite apart from her tremendous hospitality, 
Wei Wei and her husband accompanied me on very 
interesting trips to other Chinese cities to meet 
many researchers and clinicians and to see the 
sights. I shall ever be indebted to Professor Zhang 
for introducing me to so much Chinese culture and 
cuisine. 
Post-retirement 
When I was about to retire, I realised that leav-
ing what seemed like a lifetime in Neuropathology 
would be very difficult. Through the kindness of my 
colleagues, I took gradual retirement over 4-5 years 
moving to part-time involvement in clinical diagnos-
tic neuropathology. I also remain involved on a con-
sultancy basis with Professor Roxana Carare’s group 
who, following her Ph.D., developed a very success-
ful research programme in Southampton with sub-
stantial grant income. I watched with great interest 
and some advice to the development of the IPAD 
work and I was involved in the discussion during the 
preparation of papers for publication. This was very 
helpful in my disengagement from neuropathology. 
In addition, I was asked to be chairman of the Bio-
medical Grants Advisory Board for the Alzheimer’s 
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Society from 2013 to 2018 which kept me in touch 
with developments in research into Alzheimer’s dis-
ease.  
Living in Winchester gave me the opportunity 
to become a guide in the Cathedral. This 900-year-
old building and its contents are a mine of infor-
mation regarding British History in the last 2000 
years. I edited the Winchester Cathedral Record that 
published research articles concerning the Cathe-
dral for four years and I have been actively involved 
in researching the Cathedral for my own benefit and 
the benefits of my fellow guides and visitors. 
Family 
If it had not been for the support that I have 
received from my family, my career in Medicine and 
Neuropathology would not have been possible. My 
loving parents greatly encouraged me in my educa-
tion and my wife, Francine, has offered her full sup-
port to me and to our moves around the UK and 
abroad. Throughout our 60 years of happy marriage, 
I have admired Francine’s independence and I am in-
debted to her for expanding my knowledge and in-
volvement in the Arts, especially Music and Litera-
ture. We have both sung in choirs for almost the 
whole of our married life and continue to do so with 
great enjoyment. Our two children, Adrienne and 
Timothy have been a huge joy to us as have their 
spouses and our four grandchildren.  
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🎉 🎂     Celebrating Professor Roy Weller:     🎊 🥂 
83 years old, over 5 decades of contributions to 
neuropathology 
 
Prof Johannes Attems 
 
Consultant Neuropathologist, Newcastle 
University and Editor, Acta Neuropathologica 
 
The first time I met Professor Roy Weller 
was at the British Neuropathological Society 
Winter meeting in 2001; in the break after the 
session where I had presented, he - the famous 
Professor - approached me - the unknown jun-
ior Doctor from Vienna - to discuss my talk! It 
was a nearly 20 minute discussion about the 
pathogenesis of cerebral amyloid angiopathy 
and Professor Weller listened to what I had to 
say and even produced some drawings illustrat-
ing the perivascular clearance. This first meet-
ing with Professor Weller was hugely inspiring 
and motivating and certainly had a big impact 
on my decision to continue with research into 
neuropathology and I still think often back to 
this day in 2001! Naturally many more stimulat-
ing discussions  between us followed (on all top-
ics, professional and private) and I am looking 
forward to many more discussions in the future. 
Very many thanks for all your support Roy! 
 
 
Prof Roxana Carare 
 
Clinical Neurosciences, 
University of Southampton 
 
Roy Weller has catalyzed and energized 
the research into lymphatic drainage of the 
brain, inspiring and allowing us to pursue this 
with translational value for cerebral amyloid an-
giopathy and Alzheimer’s disease. He has 
taught me and many others the scientific 
method and testing hypotheses based on a 
solid overview of past and present observations 
on the human brain. The research group that I 
lead is a result of his continuous efforts to help 
with the direction of research, interpreting re-
sults, analytical, critical and forward-thinking 
discussions. We are grateful for his attention to 
detail and educating us to be researchers of 




Prof Mony de Leon 
 
Weill Cornell Medicine 
Director, Brain Health Imaging Institute 
 
I am delighted to celebrate Professor Roy 
Weller’s 80th birthday by reflecting on his con-
tributions to pathology and to radiology. How-
ever, using just a few words to do this, owing to 
his extensive and influential scholarly history, is 
a remarkably difficult but a highly refreshing 
task. Taking advantage of a personal and arbi-
trary starting point, my first encounter with 
Roy’s work was on his work in dementia and hy-
drocephalus. Weller, a longtime developer of 
animal models of hydrocephalus and an advo-
cate for innovative dementia treatment op-
tions, would write in the J Neurol Neurosurg 
Psychiatry 1989, “When confronted with a pa-
tient with dementia, gait dyspraxia, and incon-
tinence, we suggest that it is more realistic to 
look for a remediable hydrocephalic component 
to the illness than to consider that the patient 
must have either Alzheimer’s disease, multi-in-
farct dementia, or normal pressure hydroceph-
alus alone.” 
In the late 1970s I was a gerontology stu-
dent studying Alzheimer disease (AD) and in 
1980 I received an NYU-Brookhaven National 
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Lab (BNL) neuroimaging post-doctoral fellow-
ship. With the emergence of human imaging 
studies during the late 1970s, my mentor and 
colleague neuroradiologist Ajax George and I 
were awarded our first NIH-NIA funded studies 
of CT atrophy in dementia and in 1980, collabo-
ration with Alfred Wolf and Joanna Fowler at 
BNL, NIH-NINDS funded FDG-PET studies of AD 
began. At the time, it was commonly believed 
that imaging had little to contribute to the AD 
diagnosis due to background aging effects. One 
real-world test of our AD diagnostic imaging 
work was to evaluate if our measurements dif-
ferentiated between AD and hydrocephalus. 
We quantified CT scans for regional ventriculo-
megaly, evaluated compressed sulci and CSF 
pooling, we published and post mortem vali-
dated a CT scale for periventricular white mat-
ter pathology, and tested whether the hippo-
campus, a site of early AD pathology, was pre-
served in hydrocephalus. We ran FDG-PET scans 
before and after shunting looking for metabolic 
recovery, and collected biopsy samples during 
shunting for evidence for AD. This work led to 
another point of connection between my work 
and Roy Weller’s, interactions with two 
pathologists Henry Wisniewski and Robert 
Terry (both deceased) who both worked with 
Roy and who would become my valued friends 
and advisors. Today, the radiological diagnosis 
is an essential part of the differential dementia 
examination, and multiple avenues of imaging 
research, guided by Roy’s insights, continue.  
One such insight, and clearly for me, Roy’s most 
important contribution was for his anatomico-
physiological studies examining the normal and 
pathological clearance of CSF and ISF from the 
brain. These studies, which continue today, are 
now led at the University of London in South-
ampton by Professor Roxana Carare, a former 
Weller mentee. Historically, these studies re-
vealed the anatomical pathways for ISF drain-
age along basement membranes surrounding 
smooth muscle cells of cerebral arteries and 
along capillaries, and provided evidence that 
impaired interstitial flow contributed to paren-
chymal and vascular amyloid accumulations as 
well as being negatively impacted by amyloid 
accumulations. This mechanistic message was 
heard by many others, including the radiologi-
cal community where currently PET and MRI im-
aging studies are underway today translating 
the Weller and Carare observations of a direct 
link between impaired vascular biology and AD 
and most recently other neurological diseases 
defined by misfolded proteinopathies. Thus, we 
wish Roy a happy birthday and applaud him and 
his colleagues for their continued efforts to 
treat dementia by providing pathology 
grounded data and testable hypotheses. 
 
 
Prof Margaret Esiri 
 
Consultant Neuropathologist, 
John Radcliffe Hospital, Oxford  
 
I first encountered Roy at my first BNS 
meeting in (probably) 1971 or 1972. He came 
over as a calm, confident deliverer of a presen-
tation – I’ve forgotten what it was on. I think he 
may have been at Guy’s at the time. I was very 
impressed! 
I have gone on being impressed with Roy’s 
very significant contributions to neuropathol-
ogy ever since. Long may they continue! Happy 




Prof Masafumi Ihara 
 
Head of the Cardiovascular Centre, 
Osaka, Japan 
 
It is my great pleasure to contribute to an 
article celebrating Prof. Weller's 80th birthday. 
Prof. Weller is an internationally recognized 
neuropathologist and well-known to have es-
tablished the important concept of perivascular 
drainage pathway (now called IPAD) as an 
Abeta clearance system. I had been inspired 
by the concept and had a great opportunity to 
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meet him in the XVIIth International Congress 
of Neuropathology in Salzburg (ICN 2010).  I re-
member I had a good discussion with him in 
front of a poster of his team. I visited his and 
Prof. Carare’s laboratory in Southampton with 
three of my PhD students in 2012 and have 
been collaborating with the Southampton 
team. Our collaboration led to my investigator-
led clinical trial of a vasoactive drug for MCI pa-
tients to determine whether IPAD can be facili-
tated clinically. Dr. Satoshi Saito, my former 
PhD student, joined the Southampton team in 
2018, came back to Japan in 2020 after learning 
a lot not only from Prof. Carare but also from 
Prof. Weller, and is now working as a talented 
physician scientist in my department. Thus, 
Prof. Weller academically guided us as an estab-
lished neuropathologist but not only that, he 
very kindly acted as a tour guide of Winchester 
for me a few years ago! Prof. Weller has contin-
ued impacting my research team for over 10 
years with his plentiful neuropathological 
knowledge and we would like to send our heart-
felt congratulations to Prof. Weller.  
 
 
Prof Raj Kalaria 
 
Neurovascular Pathologist, 
Newcastle University and Chairman, 
International Society for Vascular Behavioral 
and Cognitive Disorders (VasCog) 
 
I had first heard about Roy from Helen 
Cserr, many moons ago! Besides the ‘art’ of 
neuropathology, Roy’s profound writings on 
drainage pathways of the brain intrigued me.  In 
the late 1980s when I was still at Case Western 
Reserve University training in vascular neuropa-
thology, I had communicated with Roy about a 
paper in Neuropathology and Applied Neurobi-
ology.  At the time, Roy was Editor-in-Chief of 
the journal.  Few years later, I met Roy face-to-
face when I was interviewed for a job in South-
ampton with the hope that the family and I 
could quickly return to England.  I did not get 
the post but I thought it was such a privilege and 
an honour to meet the pleasant and humble 
Professor Weller!  I had also thought somehow 
I should still keep in touch, especially that I de-
veloped a strong interest in cerebrovascular 
mechanisms and vascular pathology.  I was ab-
sorbed in mechanisms of cerebral amyloid angi-
opathy (CAA) although at the time I searched 
for explanations on Cystatin C CAA, which 
causes profound intracerebral haemorrhages.  
Cystatin C is enriched in the brain and CSF but it 
was also found in the cervical lymph glands of 
Icelandic patients. Using the Cystatin C reason-
ing, I was determined to disprove the giants 
Selkoe and Wisniewski, who were both propos-
ing at the time that cerebral Aβ amyloidosis was 
initiated by a protein(s) from the circulation 
(even papers in Nature) akin to the classical 
pathways discussed by Glenner and others how 
amyloidosis is caused in end organs.  Large NIH 
funds were even spent on studies how Aβ could 
be transported from the blood-to-brain rather 
than searching for routes how it leaves the 
brain.  All above was proven to be inaccurate 
and I was glad that Roy’s seminal work glued it 
altogether suggesting that Aβ is not only  pro-
duced in the brain but ‘pouring’ out of it along 
perivascular pathways as one of the main 
routes. Roy and later Roxana beautifully 
demonstrated the mechanisms involved in CAA 
and how proteins including Aβ, prions, Cystatin 
C drain out formulating the IPAD hypothesis.  
This is also of importance because we have used 
the tonsils (lymphatic nodes) to test individuals 
who might have prions and infected with new 
variant CJD.  To show, I understood the ‘drains’ 
of the brain, I was proud to give a talk on 
Weller’s Hypothesis of CAA at the ISN confer-
ence in Turin in 2004. Even though, I did not end 
up in Southampton, I am very fond of Roy and 
he has been an excellent mentor, advisor, col-
laborator and a good friend with whom one 
could relax, have a drink or two in the pub and 
discuss the ‘nuts and bolts’ of vascular neuropa-
thology rather than daily mundane matters.  
Over the years, it has been one of the most ex-
citing journeys with Roy. Our regular interac-
tions at the BNS meetings, VasCog and ISN con-
ferences including the one Roy organized in 
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2000 in Birmingham were refreshing, delightful 
and enjoyable. Having dinners at such gather-
ings and other times is something I always 
looked forward to and will cherish.  Thank you 
Roy and congratulations on reaching 80, true to 
what the Scriptures say ‘The span of our life is 
70 years or 80 if one is especially strong…’ 
(Psalms 90:10). 
 
Prof Hugh Perry 
 
Emeritus Professor, 
University of Southampton 
 
It was my pleasure to meet and get to know Roy 
Weller when I moved to Southampton in the 
late 1990s. Roy was a generous and welcoming 
colleague and as a basic scientist, mostly in-
volved in pre-clinical models, he was there to 
remind us of the need to be aware of the human 
perspective. He had a great breadth of know-
ledge in neuropathology and also an under-
standing of the history behind many key obser-
vations in neuropathology. His research into 
how interstitial fluid carrying proteins from the 
brain drained from the brain was one of his pas-
sions.  This is, of course, a very important com-
ponent of understanding interactions between 
the immune system and the central nervous 
system. As the rapidly growing field of neuroim-
munology advances so the research that Roy 
championed will remain relevant and new dis-
coveries will amplify the importance of his fa-
















Roy Weller: A pioneering neuropathologist. 
 
The first time I heard a talk given by Roy 
Weller, he was explaining the contribution of 
perivascular clearance on several brain disor-
ders. This was 1994. Perivascular clearance 
mechanisms became of clear importance for 
amyloid pathology in Alzheimer’s disease. Here, 
Prof. Weller had a strong impact on my thinking 
about how cerebral amyloid angiopathy devel-
ops in AD, namely as a result of perivascular 
clearance. For me, this could also explain inter-
actions between cerebral small vessel disease 
and hypertension with AD by impairing the peri-
vascular clearance. 
Prof. Weller’s concept of perivascular 
clearance is not only the basis of our under-
standing of cerebral amyloid angiopathy patho-
genesis but had even a bigger impact on the un-
derstanding of fluid and protein drainage of the 
brain in general. 
 
Prof Stephen Wharton 
 
Consultant Neuropathologist, 
Sheffield Institute of Translational 
Neuroscience, and Ex-Editor, Neuropathology 
and Applied Neurobiology 
 
I first came across Roy in the 1980s. I was 
presenting some (rather incomplete) results 
from my intercalated BSc project at a meeting 
of the Anatomical Society in Southampton. I re-
ceived a kind and supportive question from an 
audience member and was told, “that’s Roy 
Weller”. Later, when I began training in neuro-
pathology I used his textbook on Nervous Sys-
tem, Muscle and Eyes, part of the comprehen-
sive Symmers series and enjoyed its clarity and 
approachability. Roy of course was editor of 
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Neuropathology and Applied Neurobiology for 
ten years or so, and I had the opportunity to 
work with him more closely when I subse-
quently became Editor after Jim Lowe. Roy 
agreed to remain on the Editorial Board where 
he was always an enthusiastic contributor 
with good ideas to move the journal forward. 
He was also a great source of advice, both sci-
entific and for those tricky situations that some-
times arise with papers. Since then I have con-
tinued to enjoy conversations about neuropa-
thology at various meetings. I have always en-
joyed these stimulating conversations and I, like 
many others, have appreciated his kindness and 
advice over many years.  
 
 
